🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to investigate the safety and efficacy of rabe...
Status
Completed
Location
New York Center For Clinical Research
Start Date
2005-10
Trial ID
NCT00236197
Treatments Being Tested
To investigate esophageal reflux condition in patients with non-erosive gas...
Status
Completed
Location
Multiple Locations
Start Date
2005-05
Trial ID
NCT00165672
Treatments Being Tested
The purpose of this study is to determine whether lucitanib is safe and eff...
Status
Terminated
Location
Arizona Oncology Associates
Start Date
2014-09-09
Trial ID
NCT02202746
Treatments Being Tested
Co-selective inhibition of VEGFRs and FGFR has the potential benefit of blo...
Status
Completed
Location
Institute Gustave Roussy
Start Date
2010-07
Trial ID
NCT01283945
Treatments Being Tested
The purpose of this study is to investigate the safety and efficacy of rabe...
Status
Completed
Location
Jeffrey L. Newman
Start Date
2005-10
Trial ID
NCT00236184
Treatments Being Tested
The purpose of this study is to compare the pharmacodynamics/pharmacokineti...
Status
Completed
Location
Multiple Locations
Start Date
2010-09
Trial ID
NCT01202071
This project intends to make a study of personalized medicine evaluation sy...
Status
Unknown
Location
The 307th Hospital of Chinese People's Liberation Army
Start Date
2017-08-31
Trial ID
NCT03260179
The purpose of this study is to determine whether lucitanib is safe and eff...
Status
Terminated
Location
University of California, Los Angeles
Start Date
2014-04
Trial ID
NCT02109016
Treatments Being Tested
This is an open label, Phase 1b/2 study with multiple treatment arms evalua...
Status
Terminated
Location
Dana Farber Cancer Institute
Start Date
2019-06-28
Trial ID
NCT03992131
Treatments Being Tested
Phase II Study is to Evaluate the Safety and tolerability of AL3810 in comb...
Status
Unknown
Location
Shanghai Chest Hospital
Start Date
2019-11-14
Trial ID
NCT04254471
Treatments Being Tested